CyborD-DARA combination in first-line treatment for multiple myeloma Michael O’Dwyer, MD, PhD, from the National University of Ireland, Galway, Ireland, discusses the advantages of bringing daratumumab in the first-line setting as the CyborD-DARA combination ( cyclophosphamide, bortezomib and dexamethasone with daratumumab), for the treatment of multiple myeloma. Here, Prof. O’ Dwyer highlights that cyclophosphamide can […]

Read More

Multiple Myeloma: Stem Cell Transplant and Beyond 2021 Summary: Learn when patients with myeloma should consider transplant, steps involved in transplant, maintenance therapy options after transplant, and new therapies to manage multiple myeloma. Multiple myeloma is the most common cancer of the bone marrow. This presentation discusses transplant options and drug therapies for treating myeloma. […]

Read More